Biomarkers Journal Honors the Editors for Achieving Excellence in Journal Mentorship
On the grand occasion of Open Access week, Biomarkers Journal (eISSN: 2472-1646) expresses gratitude to all its elite panel of editorial board members for their continuous efforts, support and encouragement throughout the publication journey of the journal, right from its inception in the year 2015 and congratulates them for making the journal achieve its goals and becoming successful as one of the leading and well-recognized broadcaster of scientific outcomes and perspectives from systematic enquiry into biomarkers and oncology, globally.
The journal is extremely privileged to have Dr. Yoshihiro Kikuchi as its Editor-in-Chief, leading the board of academic editorial panel. The journal expresses appreciation for professional execution of his responsibilities which include spearheading the overall editorial activity of the journal and gaining commercial acclaim in open access publishing in addition to coining the special issue themes and guiding the compilation and production of special issues and titles as per the contemporary information demands.
Dr. Yoshihiro Kikuchi is currently working as President, Ooki Memorial Kikuchi Cancer Institue for Women, Saitama, Japan. Dr. Michel Herranz is Director of Cyclotron Radiochemistry Centre, Rua Irmans Liste Forjan, Santiago de Compostela, Spain. He has nearly two decades of professional experience in the field of Biomarkers research. His core research interests include biomarkers, oncology biomarkers, Molecular Biomarkers and Disease diagnosis. He is a member of core National committees and associations of oncology, pathology, radiology in Japan. He has authored several International publications which were widely and frequently cited all across the world. He has multiple research grants to his credit in biomarkers, oncology, Molecular Biomarkers and Inflammatory Markers. He is active participant in several International conferences on biomarkers research and cancer treatment.
ImedPub Publishing is proud to have onboard Dr. Yoshihiro Kikuchi to lead the academic and managerial team of the journal. His interest and admiration regarding Imed pub founding principles as an open access publication brand are highly appreciated and we hope to grow as a team. Dr. Yoshihiro Kikuchi consistently brings in fresh insights guided by his passion for biomarkers oriented research and he is a great asset to advance our open access model of publishing in the highly sought after field of diabetes metabolism.
Dr. Yoshihiro Kikuchi academic and research experience is highly valuable and relevant in guiding the contemporary researchers to advance scientific enquiry and explorations as well as in conducting editorship to make their research globally discoverable; helping the medical education sector avail the digital resources and helping the clinical professionals in keeping themselves updated with latest observations.